Tian-hua Wei
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Overcoming cancer therapy resistance: From drug innovation to therapeutics.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 26, 2024
Design, Synthesis, and Biological Evaluation of 3,4-Dihydroisoquinolin-1(2H)-one Derivatives as Protein Arginine Methyltransferase 5 Inhibitors for the Treatment of Non-Hodgkin's Lymphoma.
Journal: Journal of medicinal chemistry
Published: December 26, 2024
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery.
Journal: Journal of chemical information and modeling
Published: December 02, 2024
Discovery of 1-(Phenylsulfonyl)-1,2,3,4-tetrahydroquinoline Derivative as Orally Bioavailable and Safe RORγt Inverse Agonists for Potential Treatment of Rheumatoid Arthritis.
Journal: Journal of medicinal chemistry
Published: November 15, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations.
Journal: Journal of medicinal chemistry
Published: September 11, 2024
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.
Journal: Drug development research
Published: July 24, 2024
Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma.
Journal: Molecular diversity
Published: June 26, 2024
Correction to "Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging".
Journal: Journal of medicinal chemistry
Published: March 26, 2024
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.
Journal: Journal of medicinal chemistry
Published: March 14, 2024
Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.
Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.
Journal: European journal of medicinal chemistry
Published: March 06, 2024
Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.
Journal: Journal of medicinal chemistry
Published: March 05, 2024
Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia.
Journal: Bioorganic & medicinal chemistry
Published: December 11, 2023
Last Updated: 09/26/2026